HRP20050576A2 - Tetrahydroquinoline derivatives - Google Patents
Tetrahydroquinoline derivatives Download PDFInfo
- Publication number
- HRP20050576A2 HRP20050576A2 HR20050576A HRP20050576A HRP20050576A2 HR P20050576 A2 HRP20050576 A2 HR P20050576A2 HR 20050576 A HR20050576 A HR 20050576A HR P20050576 A HRP20050576 A HR P20050576A HR P20050576 A2 HRP20050576 A2 HR P20050576A2
- Authority
- HR
- Croatia
- Prior art keywords
- acetyl
- phenyl
- trimethyl
- compounds
- yield
- Prior art date
Links
- 125000000147 tetrahydroquinolinyl group Chemical class N1(CCCC2=CC=CC=C12)* 0.000 title claims description 22
- 125000003545 alkoxy group Chemical group 0.000 claims description 49
- 125000003282 alkyl amino group Chemical group 0.000 claims description 35
- -1 hydroxy, amino Chemical group 0.000 claims description 35
- 125000001072 heteroaryl group Chemical group 0.000 claims description 23
- 125000003118 aryl group Chemical group 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 11
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims description 4
- 230000035558 fertility Effects 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 125000005199 aryl carbonyloxy group Chemical group 0.000 claims description 3
- 125000005204 heteroarylcarbonyloxy group Chemical group 0.000 claims description 3
- 239000012453 solvate Substances 0.000 claims description 3
- 125000004658 aryl carbonyl amino group Chemical group 0.000 claims description 2
- 230000033228 biological regulation Effects 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 301
- 238000000034 method Methods 0.000 description 176
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 135
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 74
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 74
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 62
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 62
- 238000004128 high performance liquid chromatography Methods 0.000 description 52
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 50
- 239000000203 mixture Substances 0.000 description 49
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 43
- 239000000243 solution Substances 0.000 description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 40
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- 238000006243 chemical reaction Methods 0.000 description 37
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 36
- 239000000741 silica gel Substances 0.000 description 36
- 229910002027 silica gel Inorganic materials 0.000 description 36
- 238000004587 chromatography analysis Methods 0.000 description 35
- 239000003480 eluent Substances 0.000 description 35
- 238000002953 preparative HPLC Methods 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 239000007821 HATU Substances 0.000 description 25
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 25
- 235000019341 magnesium sulphate Nutrition 0.000 description 25
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- 125000004432 carbon atom Chemical group C* 0.000 description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 23
- 239000012044 organic layer Substances 0.000 description 23
- 239000011541 reaction mixture Substances 0.000 description 23
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 22
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 22
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 20
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 20
- 229940028334 follicle stimulating hormone Drugs 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 102000005962 receptors Human genes 0.000 description 17
- 108020003175 receptors Proteins 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical class O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 229960000583 acetic acid Drugs 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 102000008175 FSH Receptors Human genes 0.000 description 13
- 108010060374 FSH Receptors Proteins 0.000 description 13
- 235000011054 acetic acid Nutrition 0.000 description 13
- 238000002425 crystallisation Methods 0.000 description 12
- 230000008025 crystallization Effects 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- 230000009467 reduction Effects 0.000 description 12
- 238000006722 reduction reaction Methods 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- 238000010520 demethylation reaction Methods 0.000 description 11
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 11
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000006396 nitration reaction Methods 0.000 description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- 150000001555 benzenes Chemical class 0.000 description 8
- 230000017858 demethylation Effects 0.000 description 8
- 238000004108 freeze drying Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 7
- YMMHAIJRFWRDMG-UHFFFAOYSA-N 3,4,4a,5-tetrahydro-1h-quinolin-2-one Chemical class C1C=CC=C2NC(=O)CCC21 YMMHAIJRFWRDMG-UHFFFAOYSA-N 0.000 description 7
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 7
- 238000005917 acylation reaction Methods 0.000 description 7
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 7
- 230000027455 binding Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000006640 acetylation reaction Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- IRXSLJNXXZKURP-UHFFFAOYSA-N fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 6
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 6
- 150000003840 hydrochlorides Chemical class 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 150000003530 tetrahydroquinolines Chemical class 0.000 description 6
- ZNRLMGFXSPUZNR-UHFFFAOYSA-N 2,2,4-trimethyl-1h-quinoline Chemical class C1=CC=C2C(C)=CC(C)(C)NC2=C1 ZNRLMGFXSPUZNR-UHFFFAOYSA-N 0.000 description 5
- VCNGNQLPFHVODE-UHFFFAOYSA-N 5-methylthiophene-2-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)S1 VCNGNQLPFHVODE-UHFFFAOYSA-N 0.000 description 5
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 5
- 238000005614 Skraup synthesis reaction Methods 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 125000005842 heteroatom Chemical group 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 229910017604 nitric acid Inorganic materials 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 229940086542 triethylamine Drugs 0.000 description 5
- 238000010626 work up procedure Methods 0.000 description 5
- JPMRGPPMXHGKRO-UHFFFAOYSA-N 2-(chloromethyl)pyridine hydrochloride Chemical compound Cl.ClCC1=CC=CC=N1 JPMRGPPMXHGKRO-UHFFFAOYSA-N 0.000 description 4
- SFTFNJZWZHASAQ-UHFFFAOYSA-N 3,5-dibromobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC(Br)=C1 SFTFNJZWZHASAQ-UHFFFAOYSA-N 0.000 description 4
- MUDSDYNRBDKLGK-UHFFFAOYSA-N 4-methylquinoline Chemical compound C1=CC=C2C(C)=CC=NC2=C1 MUDSDYNRBDKLGK-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000003547 Friedel-Crafts alkylation reaction Methods 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 102000006771 Gonadotropins Human genes 0.000 description 4
- 108010086677 Gonadotropins Proteins 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 108700008625 Reporter Genes Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 4
- 239000012346 acetyl chloride Substances 0.000 description 4
- 230000010933 acylation Effects 0.000 description 4
- 239000005557 antagonist Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 230000001593 cAMP accumulation Effects 0.000 description 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000002622 gonadotropin Substances 0.000 description 4
- 229940094892 gonadotropins Drugs 0.000 description 4
- 125000005224 heteroarylcarbonylamino group Chemical group 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 208000000509 infertility Diseases 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 231100000535 infertility Toxicity 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- SPFHMKOJGHJBTH-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-7-methoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-3,5-dimethylbenzamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(O)C(NC(=O)C=3C=C(C)C=C(C)C=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 SPFHMKOJGHJBTH-UHFFFAOYSA-N 0.000 description 4
- 230000016087 ovulation Effects 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- JPVUWCPKMYXOKW-UHFFFAOYSA-N 4-phenylbenzoyl chloride Chemical compound C1=CC(C(=O)Cl)=CC=C1C1=CC=CC=C1 JPVUWCPKMYXOKW-UHFFFAOYSA-N 0.000 description 3
- XESZUVZBAMCAEJ-UHFFFAOYSA-N 4-tert-butylcatechol Chemical compound CC(C)(C)C1=CC=C(O)C(O)=C1 XESZUVZBAMCAEJ-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000021736 acetylation Effects 0.000 description 3
- 150000001266 acyl halides Chemical class 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 150000001448 anilines Chemical class 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 125000005044 dihydroquinolinyl group Chemical group N1(CC=CC2=CC=CC=C12)* 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- WIVYTYZCVWHWSH-UHFFFAOYSA-N tert-butyl n-(4-aminophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(N)C=C1 WIVYTYZCVWHWSH-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- OZXIZRZFGJZWBF-UHFFFAOYSA-N 1,3,5-trimethyl-2-(2,4,6-trimethylphenoxy)benzene Chemical compound CC1=CC(C)=CC(C)=C1OC1=C(C)C=C(C)C=C1C OZXIZRZFGJZWBF-UHFFFAOYSA-N 0.000 description 2
- UBCCHUWZCUEPFL-UHFFFAOYSA-N 1-[6-amino-2,2,4-trimethyl-4-phenyl-7-(pyridin-4-ylmethylamino)-3h-quinolin-1-yl]ethanone Chemical compound NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1NCC1=CC=NC=C1 UBCCHUWZCUEPFL-UHFFFAOYSA-N 0.000 description 2
- BTIUFDWKUDUFRJ-UHFFFAOYSA-N 1-[6-amino-7-(benzylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-1-yl]ethanone Chemical compound NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1NCC1=CC=CC=C1 BTIUFDWKUDUFRJ-UHFFFAOYSA-N 0.000 description 2
- GVBHRNIWBGTNQA-UHFFFAOYSA-N 2-methoxy-4-nitroaniline Chemical compound COC1=CC([N+]([O-])=O)=CC=C1N GVBHRNIWBGTNQA-UHFFFAOYSA-N 0.000 description 2
- HLAJZZSBQMLRKM-UHFFFAOYSA-N 3,5-dibromobenzoyl chloride Chemical compound ClC(=O)C1=CC(Br)=CC(Br)=C1 HLAJZZSBQMLRKM-UHFFFAOYSA-N 0.000 description 2
- GGHLXLVPNZMBQR-UHFFFAOYSA-N 3,5-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC(Cl)=CC(Cl)=C1 GGHLXLVPNZMBQR-UHFFFAOYSA-N 0.000 description 2
- UMVOQQDNEYOJOK-UHFFFAOYSA-N 3,5-dimethylbenzoic acid Chemical compound CC1=CC(C)=CC(C(O)=O)=C1 UMVOQQDNEYOJOK-UHFFFAOYSA-N 0.000 description 2
- ZDHKVKPZQKYREU-UHFFFAOYSA-N 4-(chloromethyl)pyridine;hydron;chloride Chemical compound Cl.ClCC1=CC=NC=C1 ZDHKVKPZQKYREU-UHFFFAOYSA-N 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- RDDXLTPBALMBBI-UHFFFAOYSA-N 4-methyl-1,2-dihydroquinoline Chemical class C1=CC=C2C(C)=CCNC2=C1 RDDXLTPBALMBBI-UHFFFAOYSA-N 0.000 description 2
- NNJMFJSKMRYHSR-UHFFFAOYSA-N 4-phenylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=CC=C1 NNJMFJSKMRYHSR-UHFFFAOYSA-N 0.000 description 2
- COWZPSUDTMGBAT-UHFFFAOYSA-N 5-bromothiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Br)S1 COWZPSUDTMGBAT-UHFFFAOYSA-N 0.000 description 2
- OUVFWIHVZPQHJF-UHFFFAOYSA-N 5-ethenyl-5-methylcyclohexa-1,3-diene Chemical class C=CC1(C)CC=CC=C1 OUVFWIHVZPQHJF-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 201000009273 Endometriosis Diseases 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- QUZKXLVHNYXDPF-UHFFFAOYSA-N N-[1-acetyl-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3H-quinolin-6-yl]furan-2-carboxamide Chemical compound CC(=O)N1C2=CC(=C(C(=C2C(CC1(C)C)(C)C3=CC=C(C=C3)OC)OC)NC(=O)C4=CC=CO4)OC QUZKXLVHNYXDPF-UHFFFAOYSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- MLALTJZIPKONFA-UHFFFAOYSA-N [1-acetyl-6-[(3,5-dibromobenzoyl)amino]-2,2,4-trimethyl-4-phenyl-3h-quinolin-7-yl] furan-2-carboxylate Chemical compound C=1C(Br)=CC(Br)=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OC(=O)C1=CC=CO1 MLALTJZIPKONFA-UHFFFAOYSA-N 0.000 description 2
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001263 acyl chlorides Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- PQLAYKMGZDUDLQ-UHFFFAOYSA-K aluminium bromide Chemical compound Br[Al](Br)Br PQLAYKMGZDUDLQ-UHFFFAOYSA-K 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229940124558 contraceptive agent Drugs 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 229960002598 fumaric acid Drugs 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- SHOJXDKTYKFBRD-UHFFFAOYSA-N mesityl oxide Natural products CC(C)=CC(C)=O SHOJXDKTYKFBRD-UHFFFAOYSA-N 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- CHHJSGZGULQTAB-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(propylamino)-3h-quinolin-6-yl]-5-methylthiophene-2-carboxamide Chemical compound C1=2C=C(NC(=O)C=3SC(C)=CC=3)C(NCCC)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 CHHJSGZGULQTAB-UHFFFAOYSA-N 0.000 description 2
- OQEWUUYGNLKABJ-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(pyridin-3-ylmethylamino)-3h-quinolin-6-yl]-5-methylthiophene-2-carboxamide Chemical compound C=1C=C(C)SC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1NCC1=CC=CN=C1 OQEWUUYGNLKABJ-UHFFFAOYSA-N 0.000 description 2
- SEDCADMBLPHVPD-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(pyridin-4-ylmethoxy)-3h-quinolin-6-yl]-3,5-dichlorobenzamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OCC1=CC=NC=C1 SEDCADMBLPHVPD-UHFFFAOYSA-N 0.000 description 2
- NYTSJZMMGNAIKH-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(pyridin-4-ylmethoxy)-3h-quinolin-6-yl]-5-bromo-2-(methylamino)benzamide Chemical compound CNC1=CC=C(Br)C=C1C(=O)NC1=CC(C(CC(C)(C)N2C(C)=O)(C)C=3C=CC=CC=3)=C2C=C1OCC1=CC=NC=C1 NYTSJZMMGNAIKH-UHFFFAOYSA-N 0.000 description 2
- QZZNILRKRJEHNZ-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(pyridin-4-ylmethylamino)-3h-quinolin-6-yl]-5-methylthiophene-2-carboxamide Chemical compound C=1C=C(C)SC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1NCC1=CC=NC=C1 QZZNILRKRJEHNZ-UHFFFAOYSA-N 0.000 description 2
- RNLARZAISTVBDN-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-7-(2-methylpropylamino)-4-phenyl-3h-quinolin-6-yl]-3,5-dibromobenzamide Chemical compound C1=2C=C(NC(=O)C=3C=C(Br)C=C(Br)C=3)C(NCC(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 RNLARZAISTVBDN-UHFFFAOYSA-N 0.000 description 2
- KLOKRUWHMPQNKD-UHFFFAOYSA-N n-[1-acetyl-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-3,5-dimethylbenzamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3C=C(C)C=C(C)C=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 KLOKRUWHMPQNKD-UHFFFAOYSA-N 0.000 description 2
- UZBQHWFRPTZWNV-UHFFFAOYSA-N n-[1-acetyl-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-3-chloro-2,6-dimethoxybenzamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3C(=C(Cl)C=CC=3OC)OC)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 UZBQHWFRPTZWNV-UHFFFAOYSA-N 0.000 description 2
- UXLUMPMXWOQRPE-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-7-methoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-3,5-dichlorobenzamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(O)C(NC(=O)C=3C=C(Cl)C=C(Cl)C=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 UXLUMPMXWOQRPE-UHFFFAOYSA-N 0.000 description 2
- JTKSSQJHRVPGCE-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-7-methoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-5-chlorothiophene-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(O)C(NC(=O)C=3SC(Cl)=CC=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 JTKSSQJHRVPGCE-UHFFFAOYSA-N 0.000 description 2
- RKWGTHULMACUJB-UHFFFAOYSA-N n-[1-acetyl-7-(benzylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1NCC1=CC=CC=C1 RKWGTHULMACUJB-UHFFFAOYSA-N 0.000 description 2
- YUCLCBPACRFNGU-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]furan-2-carboxamide Chemical compound C1=2C=C(NC(=O)C=3OC=CC=3)C(N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 YUCLCBPACRFNGU-UHFFFAOYSA-N 0.000 description 2
- YVEGKZYCOHUKJS-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-4-methyl-4-phenyl-2,3-dihydroquinolin-6-yl]-3,5-dibromobenzamide Chemical compound C1=2C=C(NC(=O)C=3C=C(Br)C=C(Br)C=3)C(N(C)C)=CC=2N(C(C)=O)CCC1(C)C1=CC=CC=C1 YVEGKZYCOHUKJS-UHFFFAOYSA-N 0.000 description 2
- PFWCRFFCZJZDQA-UHFFFAOYSA-N n-[1-acetyl-7-(ethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=2C=C(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)C(NCC)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 PFWCRFFCZJZDQA-UHFFFAOYSA-N 0.000 description 2
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000005932 reductive alkylation reaction Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 229960001367 tartaric acid Drugs 0.000 description 2
- IETANGBLQGLCOP-UHFFFAOYSA-N tert-butyl n-[2-[[1-acetyl-6-[(3,5-dimethylbenzoyl)amino]-2,2,4-trimethyl-4-phenyl-3h-quinolin-7-yl]oxy]ethyl]carbamate Chemical compound C1=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC(OCCNC(=O)OC(C)(C)C)=C1NC(=O)C1=CC(C)=CC(C)=C1 IETANGBLQGLCOP-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- FMCAFXHLMUOIGG-IWFBPKFRSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-formamido-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,5-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound O=CN[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(O)=O)CC1=CC(C)=C(O)C=C1C FMCAFXHLMUOIGG-IWFBPKFRSA-N 0.000 description 1
- SSEWGJUYSOIDMK-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinolin-6-amine Chemical class N1CCCC2=CC(N)=CC=C21 SSEWGJUYSOIDMK-UHFFFAOYSA-N 0.000 description 1
- MAPBYCTYIMFIBU-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinolin-7-amine Chemical class C1CCNC2=CC(N)=CC=C21 MAPBYCTYIMFIBU-UHFFFAOYSA-N 0.000 description 1
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
- RMGFLMXDCGQKPS-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine Chemical compound ClCCN1CCCC1 RMGFLMXDCGQKPS-UHFFFAOYSA-N 0.000 description 1
- FSNGFFWICFYWQC-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine;hydron;chloride Chemical compound Cl.ClCCN1CCCC1 FSNGFFWICFYWQC-UHFFFAOYSA-N 0.000 description 1
- OBOBUDMMFXRNDO-UHFFFAOYSA-N 1-(3-chloropropyl)piperidine;hydron;chloride Chemical compound Cl.ClCCCN1CCCCC1 OBOBUDMMFXRNDO-UHFFFAOYSA-N 0.000 description 1
- GTILEMNEKQIPMY-UHFFFAOYSA-N 1-(4-methyl-2h-quinolin-1-yl)ethanone Chemical compound C1=CC=C2N(C(=O)C)CC=C(C)C2=C1 GTILEMNEKQIPMY-UHFFFAOYSA-N 0.000 description 1
- XVAQPWZVQNIFJN-UHFFFAOYSA-N 1-(4-methyl-4-phenyl-2,3-dihydroquinolin-1-yl)ethanone Chemical compound C12=CC=CC=C2N(C(=O)C)CCC1(C)C1=CC=CC=C1 XVAQPWZVQNIFJN-UHFFFAOYSA-N 0.000 description 1
- NXUZBRPXVNOBMQ-UHFFFAOYSA-N 1-(4-methyl-6-nitro-4-phenyl-2,3-dihydroquinolin-1-yl)ethanone Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)CCC1(C)C1=CC=CC=C1 NXUZBRPXVNOBMQ-UHFFFAOYSA-N 0.000 description 1
- BZSZLELOBWTJRQ-UHFFFAOYSA-N 1-(5,7-dimethoxy-2,2,4-trimethylquinolin-1-yl)ethanone Chemical compound CC1=CC(C)(C)N(C(C)=O)C2=CC(OC)=CC(OC)=C21 BZSZLELOBWTJRQ-UHFFFAOYSA-N 0.000 description 1
- RTWPATFTOPMBPW-UHFFFAOYSA-N 1-(6-amino-2,2,4-trimethyl-4-phenyl-3h-quinolin-1-yl)ethanone Chemical compound C1C(C)(C)N(C(=O)C)C2=CC=C(N)C=C2C1(C)C1=CC=CC=C1 RTWPATFTOPMBPW-UHFFFAOYSA-N 0.000 description 1
- LITPTFHQJZXKAD-UHFFFAOYSA-N 1-(6-amino-4-methyl-4-phenyl-2,3-dihydroquinolin-1-yl)ethanone Chemical compound C12=CC(N)=CC=C2N(C(=O)C)CCC1(C)C1=CC=CC=C1 LITPTFHQJZXKAD-UHFFFAOYSA-N 0.000 description 1
- FRDFAZBTJZYCDY-UHFFFAOYSA-N 1-(6-amino-7-methoxy-2,2,4-trimethylquinolin-1-yl)ethanone Chemical compound CC(=O)N1C(C)(C)C=C(C)C2=C1C=C(OC)C(N)=C2 FRDFAZBTJZYCDY-UHFFFAOYSA-N 0.000 description 1
- SNSORAPLTXWLRS-UHFFFAOYSA-N 1-[5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-1-yl]ethanone Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C=C(OC)C=C2N(C(C)=O)C(C)(C)C1 SNSORAPLTXWLRS-UHFFFAOYSA-N 0.000 description 1
- LFAOVNADYCDTKA-UHFFFAOYSA-N 1-[5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-6-nitro-3h-quinolin-1-yl]ethanone Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C([N+]([O-])=O)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 LFAOVNADYCDTKA-UHFFFAOYSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- WTEXJYVDBQKVDM-UHFFFAOYSA-N 1-[6-amino-2,2,4-trimethyl-4-phenyl-7-(propylamino)-3h-quinolin-1-yl]ethanone Chemical compound C1=2C=C(N)C(NCCC)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 WTEXJYVDBQKVDM-UHFFFAOYSA-N 0.000 description 1
- DXWXISPFURWGKR-UHFFFAOYSA-N 1-[6-amino-2,2,4-trimethyl-7-(2-methylpropylamino)-4-phenyl-3h-quinolin-1-yl]ethanone Chemical compound C1=2C=C(N)C(NCC(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 DXWXISPFURWGKR-UHFFFAOYSA-N 0.000 description 1
- NLLRHLIXUBHIPF-UHFFFAOYSA-N 1-[6-amino-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-1-yl]ethanone Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(N)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 NLLRHLIXUBHIPF-UHFFFAOYSA-N 0.000 description 1
- SJRCRORBSHVBBF-UHFFFAOYSA-N 1-[6-amino-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-1-yl]ethanone Chemical compound C1=2C=C(N)C(N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 SJRCRORBSHVBBF-UHFFFAOYSA-N 0.000 description 1
- XCYONNNYBKTDFP-UHFFFAOYSA-N 1-[6-amino-7-(dimethylamino)-4-methyl-4-phenyl-2,3-dihydroquinolin-1-yl]ethanone Chemical compound C1=2C=C(N)C(N(C)C)=CC=2N(C(C)=O)CCC1(C)C1=CC=CC=C1 XCYONNNYBKTDFP-UHFFFAOYSA-N 0.000 description 1
- ZOVBJCUJIXSDFY-UHFFFAOYSA-N 1-[6-amino-7-(ethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-1-yl]ethanone Chemical compound C1=2C=C(N)C(NCC)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 ZOVBJCUJIXSDFY-UHFFFAOYSA-N 0.000 description 1
- WUEPMEXUMQVEGN-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;2,2,2-trifluoro-n-[2-[2-[(2,2,2-trifluoroacetyl)amino]ethylamino]ethyl]acetamide Chemical compound OC(=O)C(F)(F)F.FC(F)(F)C(=O)NCCNCCNC(=O)C(F)(F)F WUEPMEXUMQVEGN-UHFFFAOYSA-N 0.000 description 1
- XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 1
- FVPGJXXACUQQGV-UHFFFAOYSA-N 2-(2-chloroethyl)pyridine Chemical compound ClCCC1=CC=CC=N1 FVPGJXXACUQQGV-UHFFFAOYSA-N 0.000 description 1
- XBPPLECAZBTMMK-UHFFFAOYSA-N 2-chloro-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CCl XBPPLECAZBTMMK-UHFFFAOYSA-N 0.000 description 1
- RAGSWDIQBBZLLL-UHFFFAOYSA-N 2-chloroethyl(diethyl)azanium;chloride Chemical compound Cl.CCN(CC)CCCl RAGSWDIQBBZLLL-UHFFFAOYSA-N 0.000 description 1
- WNRGWPVJGDABME-UHFFFAOYSA-N 3,5-Dimethoxyaniline Chemical compound COC1=CC(N)=CC(OC)=C1 WNRGWPVJGDABME-UHFFFAOYSA-N 0.000 description 1
- FEXTXBAFBURKGS-UHFFFAOYSA-N 3-(chloromethyl)-5-methyl-1,2-oxazole Chemical compound CC1=CC(CCl)=NO1 FEXTXBAFBURKGS-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- CLZTVXIMOQUOEI-UHFFFAOYSA-N 3-chloro-2,6-dimethoxybenzoic acid Chemical compound COC1=CC=C(Cl)C(OC)=C1C(O)=O CLZTVXIMOQUOEI-UHFFFAOYSA-N 0.000 description 1
- BNVXYXRSJIWWDX-UHFFFAOYSA-N 4,5-dimethylfuran-2-carboxylic acid Chemical compound CC=1C=C(C(O)=O)OC=1C BNVXYXRSJIWWDX-UHFFFAOYSA-N 0.000 description 1
- NBJHDLKSWUDGJG-UHFFFAOYSA-N 4-(2-chloroethyl)morpholin-4-ium;chloride Chemical compound Cl.ClCCN1CCOCC1 NBJHDLKSWUDGJG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- UQOZBBPJEFPENP-UHFFFAOYSA-N 5,7-dimethoxy-2,2,4-trimethyl-1h-quinoline Chemical compound N1C(C)(C)C=C(C)C2=C1C=C(OC)C=C2OC UQOZBBPJEFPENP-UHFFFAOYSA-N 0.000 description 1
- QZLSBOVWPHXCLT-UHFFFAOYSA-N 5-chlorothiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Cl)S1 QZLSBOVWPHXCLT-UHFFFAOYSA-N 0.000 description 1
- CVYZKIFSCSWBSA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl 1-amino-6-methoxy-4-nitrocyclohexa-2,4-diene-1-carboxylate Chemical compound COC1C=C([N+]([O-])=O)C=CC1(N)C(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 CVYZKIFSCSWBSA-UHFFFAOYSA-N 0.000 description 1
- FMYOLSOPBFQMQZ-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(1-acetyl-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl)carbamate Chemical compound C1C(C)(C)N(C(=O)C)C2=CC=C(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)C=C2C1(C)C1=CC=CC=C1 FMYOLSOPBFQMQZ-UHFFFAOYSA-N 0.000 description 1
- QMGODWQNOYKFAL-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(1-acetyl-2,2,4-trimethyl-7-nitro-4-phenyl-3h-quinolin-6-yl)carbamate Chemical compound C1C(C)(C)N(C(=O)C)C2=CC([N+]([O-])=O)=C(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)C=C2C1(C)C1=CC=CC=C1 QMGODWQNOYKFAL-UHFFFAOYSA-N 0.000 description 1
- GUKYVXQPXCNZMA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(1-acetyl-4-methyl-4-phenyl-2,3-dihydroquinolin-6-yl)carbamate Chemical compound C12=CC(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)=CC=C2N(C(=O)C)CCC1(C)C1=CC=CC=C1 GUKYVXQPXCNZMA-UHFFFAOYSA-N 0.000 description 1
- MUNALPUYIUAKLQ-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(1-acetyl-4-methyl-7-nitro-4-phenyl-2,3-dihydroquinolin-6-yl)carbamate Chemical compound C12=CC(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)=C([N+]([O-])=O)C=C2N(C(=O)C)CCC1(C)C1=CC=CC=C1 MUNALPUYIUAKLQ-UHFFFAOYSA-N 0.000 description 1
- OMFZCUCKCSXBET-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(1-acetyl-7-amino-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl)carbamate Chemical compound C1C(C)(C)N(C(=O)C)C2=CC(N)=C(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)C=C2C1(C)C1=CC=CC=C1 OMFZCUCKCSXBET-UHFFFAOYSA-N 0.000 description 1
- IPHSOFFNTXLSEI-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(1-acetyl-7-amino-4-methyl-4-phenyl-2,3-dihydroquinolin-6-yl)carbamate Chemical compound C12=CC(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)=C(N)C=C2N(C(=O)C)CCC1(C)C1=CC=CC=C1 IPHSOFFNTXLSEI-UHFFFAOYSA-N 0.000 description 1
- MWTLOVUUWSIFND-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-[1-acetyl-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]carbamate Chemical compound C1=2C=C(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)C(N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 MWTLOVUUWSIFND-UHFFFAOYSA-N 0.000 description 1
- HFVLFFGFWSNPCQ-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-[1-acetyl-7-(dimethylamino)-4-methyl-4-phenyl-2,3-dihydroquinolin-6-yl]carbamate Chemical compound C1=2C=C(NC(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)C(N(C)C)=CC=2N(C(C)=O)CCC1(C)C1=CC=CC=C1 HFVLFFGFWSNPCQ-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 229910015845 BBr3 Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NNPMQIKVTIEEEA-UHFFFAOYSA-N C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3SC(Br)=CC=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3SC(Br)=CC=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 NNPMQIKVTIEEEA-UHFFFAOYSA-N 0.000 description 1
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108091006065 Gs proteins Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AWUZNMAQRUMBND-UHFFFAOYSA-N N-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(pyridin-2-ylmethoxy)-3H-quinolin-6-yl]-4-phenylbenzamide Chemical compound CC(=O)N1C2=CC(=C(C=C2C(CC1(C)C)(C)C3=CC=CC=C3)NC(=O)C4=CC=C(C=C4)C5=CC=CC=C5)OCC6=CC=CC=N6 AWUZNMAQRUMBND-UHFFFAOYSA-N 0.000 description 1
- 230000006181 N-acylation Effects 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 229920002472 Starch Chemical class 0.000 description 1
- 239000012317 TBTU Substances 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000002513 anti-ovulatory effect Effects 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 150000001793 charged compounds Chemical group 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 201000003585 eunuchism Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 230000008217 follicular development Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000006543 gametophyte development Effects 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003668 hormone analog Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011967 lanthanide triflate Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000037106 male hypogonadism Diseases 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- FKZKVFSPQAPOCL-UHFFFAOYSA-N n,n-dimethyl-1,2,3,4-tetrahydroquinolin-7-amine Chemical class C1CCNC2=CC(N(C)C)=CC=C21 FKZKVFSPQAPOCL-UHFFFAOYSA-N 0.000 description 1
- DAQFCMICJCPXGO-UHFFFAOYSA-N n-(1-acetyl-7-hydroxy-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl)-3,5-dibromobenzamide Chemical compound C1=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC(O)=C1NC(=O)C1=CC(Br)=CC(Br)=C1 DAQFCMICJCPXGO-UHFFFAOYSA-N 0.000 description 1
- INVMUBKSXAWBLP-UHFFFAOYSA-N n-(1-acetyl-7-hydroxy-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl)-3,5-dichlorobenzamide Chemical compound C1=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC(O)=C1NC(=O)C1=CC(Cl)=CC(Cl)=C1 INVMUBKSXAWBLP-UHFFFAOYSA-N 0.000 description 1
- YEMMDFHCJJHAHK-UHFFFAOYSA-N n-(1-acetyl-7-hydroxy-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl)-3,5-dimethylbenzamide Chemical compound C1=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC(O)=C1NC(=O)C1=CC(C)=CC(C)=C1 YEMMDFHCJJHAHK-UHFFFAOYSA-N 0.000 description 1
- UAXQLYFZTNWEQJ-UHFFFAOYSA-N n-(1-acetyl-7-hydroxy-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl)-4-phenylbenzamide Chemical compound C1=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC(O)=C1NC(=O)C(C=C1)=CC=C1C1=CC=CC=C1 UAXQLYFZTNWEQJ-UHFFFAOYSA-N 0.000 description 1
- MKGQERTWOKDBJO-UHFFFAOYSA-N n-(1-acetyl-7-methoxy-2,2,4-trimethylquinolin-6-yl)-3,5-dibromobenzamide Chemical compound COC1=CC=2N(C(C)=O)C(C)(C)C=C(C)C=2C=C1NC(=O)C1=CC(Br)=CC(Br)=C1 MKGQERTWOKDBJO-UHFFFAOYSA-N 0.000 description 1
- PAPHGCWETJBXCC-UHFFFAOYSA-N n-(1-acetyl-7-methoxy-2,2,4-trimethylquinolin-6-yl)-3,5-dichlorobenzamide Chemical compound COC1=CC=2N(C(C)=O)C(C)(C)C=C(C)C=2C=C1NC(=O)C1=CC(Cl)=CC(Cl)=C1 PAPHGCWETJBXCC-UHFFFAOYSA-N 0.000 description 1
- QEAITOJTOCEJDO-UHFFFAOYSA-N n-(1-acetyl-7-methoxy-2,2,4-trimethylquinolin-6-yl)-3,5-dimethylbenzamide Chemical compound COC1=CC=2N(C(C)=O)C(C)(C)C=C(C)C=2C=C1NC(=O)C1=CC(C)=CC(C)=C1 QEAITOJTOCEJDO-UHFFFAOYSA-N 0.000 description 1
- RHUUSOFNIRGIEQ-UHFFFAOYSA-N n-(1-acetyl-7-methoxy-2,2,4-trimethylquinolin-6-yl)-4-phenylbenzamide Chemical compound COC1=CC=2N(C(C)=O)C(C)(C)C=C(C)C=2C=C1NC(=O)C(C=C1)=CC=C1C1=CC=CC=C1 RHUUSOFNIRGIEQ-UHFFFAOYSA-N 0.000 description 1
- XKWHFFKWWMJBTE-UHFFFAOYSA-N n-(1-acetyl-7-methoxy-2,2,4-trimethylquinolin-6-yl)-5-bromo-2-(methylamino)benzamide Chemical compound CNC1=CC=C(Br)C=C1C(=O)NC(C(=C1)OC)=CC2=C1N(C(C)=O)C(C)(C)C=C2C XKWHFFKWWMJBTE-UHFFFAOYSA-N 0.000 description 1
- QBJWNDKUKBIVEC-UHFFFAOYSA-N n-(3-chloropropyl)morpholine-4-carboxamide Chemical compound ClCCCNC(=O)N1CCOCC1 QBJWNDKUKBIVEC-UHFFFAOYSA-N 0.000 description 1
- CYLZVQDXBQOECD-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(2-pyrrolidin-1-ylethoxy)-3h-quinolin-6-yl]-3,5-dimethylbenzamide Chemical compound C=1C(C)=CC(C)=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OCCN1CCCC1 CYLZVQDXBQOECD-UHFFFAOYSA-N 0.000 description 1
- KQNMSPSEEPVZCL-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(3-piperidin-1-ylpropoxy)-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OCCCN1CCCCC1 KQNMSPSEEPVZCL-UHFFFAOYSA-N 0.000 description 1
- UNIVKJKTCIFWSA-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(pyridin-3-ylmethoxy)-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OCC1=CC=CN=C1 UNIVKJKTCIFWSA-UHFFFAOYSA-N 0.000 description 1
- APNOMWPSZAXJSI-UHFFFAOYSA-N n-[1-acetyl-2,2,4-trimethyl-4-phenyl-7-(pyridin-4-ylmethoxy)-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OCC1=CC=NC=C1 APNOMWPSZAXJSI-UHFFFAOYSA-N 0.000 description 1
- QMFUXEHJYYIDJZ-UHFFFAOYSA-N n-[1-acetyl-5,7-dihydroxy-4-(4-hydroxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound OC1=C2C(C)(C=3C=CC(O)=CC=3)CC(C)(C)N(C(=O)C)C2=CC(O)=C1NC(=O)C(C=C1)=CC=C1C1=CC=CC=C1 QMFUXEHJYYIDJZ-UHFFFAOYSA-N 0.000 description 1
- BPQRUPWGFLJUOJ-UHFFFAOYSA-N n-[1-acetyl-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-3,5-dichlorobenzamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3C=C(Cl)C=C(Cl)C=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 BPQRUPWGFLJUOJ-UHFFFAOYSA-N 0.000 description 1
- DOTYTSHMPNKKNE-UHFFFAOYSA-N n-[1-acetyl-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-4,5-dimethylfuran-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3OC(C)=C(C)C=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 DOTYTSHMPNKKNE-UHFFFAOYSA-N 0.000 description 1
- KFVALHVIPPEAEP-UHFFFAOYSA-N n-[1-acetyl-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 KFVALHVIPPEAEP-UHFFFAOYSA-N 0.000 description 1
- OYJZHYOMJVKYSP-UHFFFAOYSA-N n-[1-acetyl-5,7-dimethoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-5-chlorothiophene-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(OC)C(NC(=O)C=3SC(Cl)=CC=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 OYJZHYOMJVKYSP-UHFFFAOYSA-N 0.000 description 1
- CIKJGYICQHFDPS-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-4-(4-hydroxyphenyl)-7-methoxy-2,2,4-trimethyl-3h-quinolin-6-yl]-3,5-dichlorobenzamide Chemical compound C1=2C(O)=C(NC(=O)C=3C=C(Cl)C=C(Cl)C=3)C(OC)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=C(O)C=C1 CIKJGYICQHFDPS-UHFFFAOYSA-N 0.000 description 1
- VCXBGUZCDUZDSN-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-4-(4-hydroxyphenyl)-7-methoxy-2,2,4-trimethyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=2C(O)=C(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)C(OC)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=C(O)C=C1 VCXBGUZCDUZDSN-UHFFFAOYSA-N 0.000 description 1
- MIJCVEVTXYXGQY-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-7-methoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-4,5-dimethylfuran-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(O)C(NC(=O)C=3OC(C)=C(C)C=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 MIJCVEVTXYXGQY-UHFFFAOYSA-N 0.000 description 1
- RMZXHAQPJSFQLI-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-7-methoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(O)C(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 RMZXHAQPJSFQLI-UHFFFAOYSA-N 0.000 description 1
- IKTGUZQARCTMBG-UHFFFAOYSA-N n-[1-acetyl-5-hydroxy-7-methoxy-4-(4-methoxyphenyl)-2,2,4-trimethyl-3h-quinolin-6-yl]furan-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C1(C)C2=C(O)C(NC(=O)C=3OC=CC=3)=C(OC)C=C2N(C(C)=O)C(C)(C)C1 IKTGUZQARCTMBG-UHFFFAOYSA-N 0.000 description 1
- RPOWBHCDORNIIP-UHFFFAOYSA-N n-[1-acetyl-7-(2-amino-2-oxoethoxy)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC(OCC(N)=O)=C1NC(=O)C(C=C1)=CC=C1C1=CC=CC=C1 RPOWBHCDORNIIP-UHFFFAOYSA-N 0.000 description 1
- OGCRMHGHVGPYKG-UHFFFAOYSA-N n-[1-acetyl-7-(2-aminoethoxy)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-3,5-dibromobenzamide Chemical compound C1=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC(OCCN)=C1NC(=O)C1=CC(Br)=CC(Br)=C1 OGCRMHGHVGPYKG-UHFFFAOYSA-N 0.000 description 1
- DAUKGCGNYPEUBA-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-2-methylpropanamide Chemical compound C1=C(N(C)C)C(NC(=O)C(C)C)=CC2=C1N(C(C)=O)C(C)(C)CC2(C)C1=CC=CC=C1 DAUKGCGNYPEUBA-UHFFFAOYSA-N 0.000 description 1
- IPJOAOFPAGHTKS-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-3,5-dibromobenzamide Chemical compound C1=2C=C(NC(=O)C=3C=C(Br)C=C(Br)C=3)C(N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 IPJOAOFPAGHTKS-UHFFFAOYSA-N 0.000 description 1
- PBSMJYDUUVOGPD-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=2C=C(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)C(N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 PBSMJYDUUVOGPD-UHFFFAOYSA-N 0.000 description 1
- AXXGPFSJFZTFBT-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-5-methylthiophene-2-carboxamide Chemical compound C1=2C=C(NC(=O)C=3SC(C)=CC=3)C(N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 AXXGPFSJFZTFBT-UHFFFAOYSA-N 0.000 description 1
- BVYXCJFSBSNAGH-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]cyclopentanecarboxamide Chemical compound C1=2C=C(NC(=O)C3CCCC3)C(N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 BVYXCJFSBSNAGH-UHFFFAOYSA-N 0.000 description 1
- QKMMTYPVUGPQAT-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-4-methyl-4-phenyl-2,3-dihydroquinolin-6-yl]-5-bromothiophene-2-carboxamide Chemical compound C1=2C=C(NC(=O)C=3SC(Br)=CC=3)C(N(C)C)=CC=2N(C(C)=O)CCC1(C)C1=CC=CC=C1 QKMMTYPVUGPQAT-UHFFFAOYSA-N 0.000 description 1
- INANQOGCIOGHJO-UHFFFAOYSA-N n-[1-acetyl-7-(dimethylamino)-4-methyl-4-phenyl-2,3-dihydroquinolin-6-yl]-5-chlorothiophene-2-carboxamide Chemical compound C1=2C=C(NC(=O)C=3SC(Cl)=CC=3)C(N(C)C)=CC=2N(C(C)=O)CCC1(C)C1=CC=CC=C1 INANQOGCIOGHJO-UHFFFAOYSA-N 0.000 description 1
- ZAEPSQIVZXZUTA-UHFFFAOYSA-N n-[1-acetyl-7-(furan-2-carbonylamino)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]furan-2-carboxamide Chemical compound C=1C=COC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1NC(=O)C1=CC=CO1 ZAEPSQIVZXZUTA-UHFFFAOYSA-N 0.000 description 1
- OAXZBHAZXQTFFY-UHFFFAOYSA-N n-[1-acetyl-7-(furan-2-ylmethoxy)-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-3,5-dimethylbenzamide Chemical compound C=1C(C)=CC(C)=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OCC1=CC=CO1 OAXZBHAZXQTFFY-UHFFFAOYSA-N 0.000 description 1
- IFBQSRLVXWOMBC-UHFFFAOYSA-N n-[1-acetyl-7-[2-(diethylamino)ethoxy]-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-3,5-dimethylbenzamide Chemical compound C1=2C=C(NC(=O)C=3C=C(C)C=C(C)C=3)C(OCCN(CC)CC)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 IFBQSRLVXWOMBC-UHFFFAOYSA-N 0.000 description 1
- GATUWHJNCOKBJY-UHFFFAOYSA-N n-[1-acetyl-7-[2-(dimethylamino)-2-oxoethoxy]-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=2C=C(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)C(OCC(=O)N(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 GATUWHJNCOKBJY-UHFFFAOYSA-N 0.000 description 1
- UFNDENPZSPUGBV-UHFFFAOYSA-N n-[1-acetyl-7-[2-(dimethylamino)ethoxy]-2,2,4-trimethyl-4-phenyl-3h-quinolin-6-yl]-4-phenylbenzamide Chemical compound C1=2C=C(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)C(OCCN(C)C)=CC=2N(C(C)=O)C(C)(C)CC1(C)C1=CC=CC=C1 UFNDENPZSPUGBV-UHFFFAOYSA-N 0.000 description 1
- BELUGESNSXPHEC-UHFFFAOYSA-N n-[3-[[1-acetyl-2,2,4-trimethyl-4-phenyl-6-[(4-phenylbenzoyl)amino]-3h-quinolin-7-yl]oxy]propyl]morpholine-4-carboxamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)NC=1C=C2C(C)(C=3C=CC=CC=3)CC(C)(C)N(C(=O)C)C2=CC=1OCCCNC(=O)N1CCOCC1 BELUGESNSXPHEC-UHFFFAOYSA-N 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 230000000802 nitrating effect Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- BGUWFUQJCDRPTL-UHFFFAOYSA-N pyridine-4-carbaldehyde Chemical compound O=CC1=CC=NC=C1 BGUWFUQJCDRPTL-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940075993 receptor modulator Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000027272 reproductive process Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- HZXJVDYQRYYYOR-UHFFFAOYSA-K scandium(iii) trifluoromethanesulfonate Chemical compound [Sc+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F HZXJVDYQRYYYOR-UHFFFAOYSA-K 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002863 seminiferous tubule Anatomy 0.000 description 1
- 210000000717 sertoli cell Anatomy 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008107 starch Chemical class 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000010009 steroidogenesis Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- IBZVSQSOMRCRCD-UHFFFAOYSA-N tert-butyl n-(1-acetyl-2,2,4-trimethylquinolin-6-yl)carbamate Chemical compound C1=C(NC(=O)OC(C)(C)C)C=C2C(C)=CC(C)(C)N(C(=O)C)C2=C1 IBZVSQSOMRCRCD-UHFFFAOYSA-N 0.000 description 1
- TXFUWJLANVJXMK-UHFFFAOYSA-N tert-butyl n-(2,2,4-trimethyl-1h-quinolin-6-yl)carbamate Chemical compound C1=C(NC(=O)OC(C)(C)C)C=C2C(C)=CC(C)(C)NC2=C1 TXFUWJLANVJXMK-UHFFFAOYSA-N 0.000 description 1
- GPTXCAZYUMDUMN-UHFFFAOYSA-N tert-butyl n-(2-hydroxyethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCO GPTXCAZYUMDUMN-UHFFFAOYSA-N 0.000 description 1
- QKSQWQOAUQFORH-UHFFFAOYSA-N tert-butyl n-[(2-methylpropan-2-yl)oxycarbonylimino]carbamate Chemical compound CC(C)(C)OC(=O)N=NC(=O)OC(C)(C)C QKSQWQOAUQFORH-UHFFFAOYSA-N 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43504002P | 2002-12-20 | 2002-12-20 | |
EP02102866 | 2002-12-20 | ||
PCT/EP2003/051025 WO2004056780A2 (en) | 2002-12-20 | 2003-12-16 | Tetrahydroquinoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20050576A2 true HRP20050576A2 (en) | 2005-10-31 |
Family
ID=32683821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20050576A HRP20050576A2 (en) | 2002-12-20 | 2005-06-20 | Tetrahydroquinoline derivatives |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20050084341A (de) |
CO (1) | CO5590903A2 (de) |
DE (1) | DE60326390D1 (de) |
EC (1) | ECSP055871A (de) |
EG (1) | EG24958A (de) |
HK (1) | HK1077577A1 (de) |
HR (1) | HRP20050576A2 (de) |
IS (1) | IS2647B (de) |
MX (1) | MXPA05006767A (de) |
NO (1) | NO330612B1 (de) |
-
2003
- 2003-12-16 MX MXPA05006767A patent/MXPA05006767A/es active IP Right Grant
- 2003-12-16 DE DE60326390T patent/DE60326390D1/de not_active Expired - Lifetime
- 2003-12-16 KR KR1020057011089A patent/KR20050084341A/ko active IP Right Grant
-
2005
- 2005-05-26 IS IS7871A patent/IS2647B/is unknown
- 2005-06-07 NO NO20052727A patent/NO330612B1/no not_active IP Right Cessation
- 2005-06-18 EG EGNA2005000309 patent/EG24958A/xx active
- 2005-06-20 HR HR20050576A patent/HRP20050576A2/hr not_active Application Discontinuation
- 2005-06-20 EC EC2005005871A patent/ECSP055871A/es unknown
- 2005-07-19 CO CO05071364A patent/CO5590903A2/es not_active Application Discontinuation
- 2005-12-28 HK HK05112055.2A patent/HK1077577A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20052727L (no) | 2005-07-13 |
DE60326390D1 (en) | 2009-04-09 |
ECSP055871A (es) | 2005-09-20 |
IS7871A (is) | 2005-05-26 |
EG24958A (en) | 2011-02-28 |
CO5590903A2 (es) | 2005-12-30 |
MXPA05006767A (es) | 2005-09-08 |
HK1077577A1 (en) | 2006-02-17 |
NO20052727D0 (no) | 2005-06-07 |
KR20050084341A (ko) | 2005-08-26 |
NO330612B1 (no) | 2011-05-30 |
IS2647B (is) | 2010-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003303221B2 (en) | Tetrahydroquinoline derivatives and their use as FSH receptor modulators | |
EP1578726B1 (de) | Tetrahydrochinolinderivate | |
HRP20031080A2 (en) | Tetrahydroquinoline derivatives | |
AU2006243194B2 (en) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility | |
JP2010536934A (ja) | Tsh受容体拮抗性のテトラヒドロキノリン化合物 | |
ZA200504775B (en) | Tetrahydroquinoline derivatives | |
HRP20050576A2 (en) | Tetrahydroquinoline derivatives | |
HRP20050577A2 (en) | Tetrahydroquinoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
PPPP | Transfer of rights |
Owner name: N.V. ORGANON, NL |
|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20101208 Year of fee payment: 8 |
|
OBST | Application withdrawn |